Prevent Kidney Disease
Learn more to reduce your risk of kidney disease and take the pledge to #preventkidneydisease.
We regret to inform you that, due to budgetary shortfalls at the National Kidney Foundation, there will be no new funding available for KDOQI Research grants in 2011. This means that we will not be able to issue a new RFA at this time.
NKF is currently funding four KDOQI research grants at $150,000/yr, and anticipates that the RFA will be issued as soon as sufficient funds become available for additional awards. Thank you for your continued support of NKF and KDOQI.
Click on the following links to learn more about KDOQI research:
Sun Woo, MD and PhD, studies hypertensive kidney disease at the Center for Human Genomics at University of California at San Diego with NKF support.
The National Kidney Foundation’s newest research grant initiative stimulates investigation addressing the research recommendations that accompany each Kidney Disease Outcomes Quality Initiative (KDOQI) guideline.
Answering these questions will enable KDOQI to provide more authoritative guidance regarding appropriate tests and therapies in the future, lead to enhanced patient outcomes, advance patient advocacy and, ultimately, validate, critique, and improve guidelines. It is hoped that studies of guideline implementation efforts will also contribute to the effective utilization of KDOQI guidelines and clinical practice recommendations.
NKF plans to fund two new KDOQI research grants each fiscal year. Each will provide support at the level of $150,000, per annum, for three years. Funding will be limited to projects that are responsive to an annual Request For Applications (RFA). Funding is available to investigators at any stage of their career, as long as there is no scientific or budgetary overlap with other research support.
Topics for the KDOQI RFA, issued annually in September, are selected by the KDOQI Research Advisory Committee based upon the following criteria:
KDOQI Research Grant support could fund work such as pilot studies related to the KDOQI research recommendations, proof of concept or feasibility studies that, in turn, would provide preliminary data on which applications for NIH support could be based. Secondary analysis of existing data bases such as ancillary studies in connection with ongoing randomized clinical trials and observational cohort studies may also be appropriate.
Potential applicants should also be aware of the following principles:
For additional information, please send an email to email@example.com.